Have a personal or library account? Click to login
Treatment of Sydenham’s Chorea: A Review of the Current Evidence Cover

Treatment of Sydenham’s Chorea: A Review of the Current Evidence

Tremor and Other Hyperkinetic Movements
Volume 7 (2017): Issue 0
By: Shannon L. Dean and  Harvey S. Singer  
Open Access
|Jun 2017

References

  1. 1
    PunukolluMMushetNLinneyMHennessyCMortonMNeuropsychiatric manifestations of Sydenham’s chorea: a systematic reviewDev Med Child Neurol2016581628doi: 10.1111/dmcn.1278625926089
    Back to article
  2. 2
    MoreiraJKummerAHarsanyiECardosoFTeixeiraALPsychiatric disorders in persistent and remitted Sydenham’s choreaParkinsonism Relat Disord201420233236doi: 10.1016/j.parkreldis.2013.10.02924268384
    Back to article
  3. 3
    CavalcantiAHilarioMOdos SantosFHBolognaniSABuenoOFLenCASubtle cognitive deficits in adults with a previous history of Sydenham’s chorea during childhoodArthritis Care Res (Hoboken)20106210651071doi: 10.1002/acr.2019120235195
    Back to article
  4. 4
    PanamontaMChaikitpinyoAAuvichayapatNWeraarchakulWPanamontaOPantongwiriyakulAEvolution of valve damage in Sydenham’s chorea during recurrence of rheumatic feverInt J Cardiol20071197379doi: 10.1016/j.ijcard.2006.07.07717049647
    Back to article
  5. 5
    GurkasEKaralokZSTaskinBDet alPredictors of recurrence in Sydenham’s chorea: clinical observation from a single centerBrain Dev201638827doi: 10.1016/j.braindev.2016.04.01027209549
    Back to article
  6. 6
    CardosoFVargasAPOliveiraLDGuerraAAAmaralSVPersistent Sydenham’s choreaMov Disord199914805807doi: 10.1002/1531-8257(199909)14:5<805::AID-MDS1013>3.0.CO;2-P10495042
    Back to article
  7. 7
    Korn-LubetzkiIBrandASteinerIRecurrence of Sydenham chorea: implications for pathogenesisArch Neurol20046112611264doi: 10.1001/archneur.61.2.27315313844
    Back to article
  8. 8
    MaiaDPFonsecaPGCamargosSTPfannesCCunninghamMCCardosoFPregnancy in patients with Sydenham’s choreaParkinsonism Relat Disord201218458461doi: 10.1016/j.parkreldis.2011.12.01322236583
    Back to article
  9. 9
    GieddJNRapoportJLKruesiMJet alSydenham’s chorea: magnetic resonance imaging of the basal gangliaNeurology19954521992202doi: 10.1212/WNL.45.12.21998848193
    Back to article
  10. 10
    FaustinoPCTerreriMTda RochaAJZappitelliMCLedermanHMHilarioMOClinical, laboratory, psychiatric and magnetic resonance findings in patients with Sydenham choreaNeuroradiology200345456462doi: 10.1007/s00234-003-0999-812811441
    Back to article
  11. 11
    HusbyGvan de RijnIZabriskieJBAbdinZHWilliamsRCJrAntibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic feverJ Exp Med197614410941110doi: 10.1084/jem.144.4.1094789810
    Back to article
  12. 12
    KirvanCASwedoSEHeuserJSCunninghamMWMimicry and autoantibody-mediated neuronal cell signaling in Sydenham choreaNat Med20039914920doi: 10.1038/nm89212819778
    Back to article
  13. 13
    KirvanCASwedoSEKuraharaDCunninghamMWStreptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham’s choreaAutoimmunity2006392129doi: 10.1080/0891693050048475716455579
    Back to article
  14. 14
    CunninghamMWCoxCJAutoimmunity against dopamine receptors in neuropsychiatric and movement disorders: a review of Sydenham chorea and beyondActa Physiol (Oxf)201621690100doi: 10.1111/apha.1261426454143
    Back to article
  15. 15
    Ben-PaziHStonerJACunninghamMWDopamine receptor autoantibodies correlate with symptoms in Sydenham’s choreaPLoS ONE20138e73516doi: 10.1371/journal.pone.007351624073196
    Back to article
  16. 16
    CoxCJSharmaMLeckmanJFet alBrain human monoclonal autoantibody from Sydenham chorea targets dopaminergic neurons in transgenic mice and signals dopamine D2 receptor: implications in human diseaseJ Immunol201319155245541doi: 10.4049/jimmunol.110259224184556
    Back to article
  17. 17
    BrimbergLBenharIMascaro-BlancoAet alBehavioral, pharmacological, and immunological abnormalities after streptococcal exposure: a novel rat model of Sydenham chorea and related neuropsychiatric disordersNeuropsychopharmacology20123720762087doi: 10.1038/npp.2012.5622534626
    Back to article
  18. 18
    DaleRCMerhebVPillaiSet alAntibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disordersBrain2012135(Pt 11)34533468doi: 10.1093/brain/aws25623065479
    Back to article
  19. 19
    AlvarezLANovakGValproic acid in the treatment of Sydenham choreaPediatr Neurol19851317319doi: 10.1016/0887-8994(85)90037-23939747
    Back to article
  20. 20
    DemirorenKYavuzHCamLOranBKaraaslanSDemirorenSSydenham’s chorea: a clinical follow-up of 65 patientsJ Child Neurol200722550554doi: 10.1177/088307380730261417690060
    Back to article
  21. 21
    DhanarajMRadhakrishnanARSrinivasKSayeedZASodium valproate in Sydenham’s choreaNeurology198535114115doi: 10.1212/WNL.35.1.1143917559
    Back to article
  22. 22
    McLachlanRSValproic acid in Sydenham’s choreaBr Med J (Clin Res Ed)1981283274275doi: 10.1136/bmj.283.6286.274
    Back to article
  23. 23
    SabuiTKPantPSodium valproate in the treatment of Sydenham’s choreaIndian J Pediatr201077703doi: 10.1007/s12098-010-0074-520454934
    Back to article
  24. 24
    HarelLZechariaAStraussbergRVolovitzBAmirJSuccessful treatment of rheumatic chorea with carbamazepinePediatr Neurol200023147151doi: 10.1016/S0887-8994(00)00177-611020640
    Back to article
  25. 25
    PeñaJMoraECardozoJMolinaOMontielCComparison of the efficacy of carbamazepine, haloperidol and valproic acid in the treatment of children with Sydenham’s chorea: clinical follow-up of 18 patientsArq Neuropsiquiatr200260374377doi: 10.1590/S0004-282X200200030000612131934
    Back to article
  26. 26
    GenelFArslanogluSUranNSaylanBSydenham’s chorea: clinical findings and comparison of the efficacies of sodium valproate and carbamazepine regimensBrain Dev2002247376doi: 10.1016/S0387-7604(01)00404-111891095
    Back to article
  27. 27
    GreenLNCorticosteroids in the treatment of Sydenham’s choreaArch Neurol1978355354doi: 10.1001/archneur.1978.00500250057015202236
    Back to article
  28. 28
    van ImmerzeelTDvan GilstRMHartwigNGBeneficial use of immunoglobulins in the treatment of Sydenham choreaEur J Pediatr2010169(9)11511154doi: 10.1007/s00431-010-1172-020349351
    Back to article
  29. 29
    MirandaMWalkerRHSaezDRennerVSevere Sydenham’s chorea (chorea paralytica) successfully treated with plasmapheresisJ Clin Mov Disord201522doi: 10.1186/s40734-014-0012-126788338
    Back to article
  30. 30
    DavutogluVKilincMDinckalHSoydincSSezenYSydenham’s chorea-clinical characteristics of nine patientsInt J Cardiol200496483484doi: 10.1016/j.ijcard.2003.05.03915301906
    Back to article
  31. 31
    TumasVCaldasCTSantosACNobreAFernandesRMSydenham's chorea: clinical observations from a Brazilian movement disorder clinicParkinsonism Relat Disord200713276283doi: 10.1016/j.parkreldis.2006.11.01017240185
    Back to article
  32. 32
    BarashJMargalithDMatitiauACorticosteroid treatment in patients with Sydenham’s choreaPediatr Neurol200532205207doi: 10.1016/j.pediatrneurol.2004.09.01215730904
    Back to article
  33. 33
    ShenkerDMGrossmanHJKlawansHLTreatment of Sydenham's chorea with haloperidolDev Med Child Neurol1973151924doi: 10.1111/j.1469-8749.1973.tb04861.x4729410
    Back to article
  34. 34
    AppletonREJanJEEfficacy of valproic acid in the treatment of Sydenham’s choreaJ Child Neurol19883147doi: 10.1177/088307388800300214
    Back to article
  35. 35
    ShannonKMFenichelGMPimozide treatment of Sydenham’s choreaNeurology199040186doi: 10.1212/WNL.40.1.186
    Back to article
  36. 36
    DaoudASZakiMShakirRal-SalehQEffectiveness of sodium valproate in the treatment of Sydenham's choreaNeurology19904011401141doi: 10.1212/WNL.40.7.11402113207
    Back to article
  37. 37
    Harries-JonesRGibsonJGSuccessful treatment of refractory Sydenham’s chorea with pimozideJ Neurol Neurosurg Psychiatry198548390doi: 10.1136/jnnp.48.4.390
    Back to article
  38. 38
    HawkesCHNourseCHTetrabenazine in Sydenham’s choreaBr Med J1977113911392doi: 10.1136/bmj.1.6073.1391-a
    Back to article
  39. 39
    AxleyJRheumatic chorea controlled with haloperidolJ Pediatr19728112161217doi: 10.1016/S0022-3476(72)80272-54643046
    Back to article
  40. 40
    ZakiSALadVShanbagPQuadriparesis and dysarthria due to tetrabenazine therapy in a child with rheumatic choreaIndian J Pharmacol201143601602doi: 10.4103/0253-7613.8498222022010
    Back to article
  41. 41
    BalottinUCalcaterraEZamboninFVeggiottiPLuoniCTermineCChorea mollis: long-term follow-up of an infantile caseNeurol Sci201233643645doi: 10.1007/s10072-011-0806-y21948058
    Back to article
  42. 42
    KulkarniMLAneesSSydenham’s choreaIndian Pediatr1996331121158772928
    Back to article
  43. 43
    AraujoAPPaduaPAMaia FilhoHSManagement of rheumatic chorea: an observational studyArq Neuropsiquiatr200260231233doi: 10.1590/S0004-282X200200020000812068350
    Back to article
  44. 44
    RoigMMontserratLGallartACarbamazepine: an alternative drug for the treatment of nonhereditary choreaPediatrics198882(Pt 2)4924952970059
    Back to article
  45. 45
    SteinbergAReifenRMLeiferMEfficacy of valproic acid in the treatment of Sydenham’s choreaJ Child Neurol19872233234doi: 10.1177/0883073887002003123112212
    Back to article
  46. 46
    SethiSSetiyaRLallarKSuccessful treatment of Sydenham chorea with olanzapineJ Pediatr Neurol20064171174
    Back to article
  47. 47
    RawatMSPatelABTheteARBokdeCRole of vitamin E in rheumatic choreaIndian J Pediatr200067563566doi: 10.1007/BF0275847910984995
    Back to article
  48. 48
    CardosoFMaiaDCunninghamMCValencaGTreatment of Sydenham chorea with corticosteroidsMov Disord20031813741377doi: 10.1002/mds.1052114639684
    Back to article
  49. 49
    PazJASilvaCAMarques-DiasMJRandomized double-blind study with prednisone in Sydenham's choreaPediatr Neurol200634264269doi: 10.1016/j.pediatrneurol.2005.08.02816638499
    Back to article
  50. 50
    WalkerKBrinkALawrensonJMathiassenWWilmshurstJMTreatment of Sydenham chorea with intravenous immunoglobulinJ Child Neurol201227147155doi: 10.1177/088307381141405821868369
    Back to article
  51. 51
    GarveyMASniderLALeitmanSFWerdenRSwedoSETreatment of Sydenham's chorea with intravenous immunoglobulin, plasma exchange, or prednisoneJ Child Neurol200520424429doi: 10.1177/0883073805020005060115968928
    Back to article
  52. 52
    BoersmaNASchippersHKuijpersTHeidemaJSuccessful treatment of Sydenham’s chorea with intravenous immunoglobulinBMJ Case Rep20162016doi: 10.1136/bcr-2015-211673
    Back to article
  53. 53
    FuscoCUcchinoVFrattiniDPisaniFDella GiustinaEAcute and chronic corticosteroid treatment of ten patients with paralytic form of Sydenham’s choreaEur J Paediatr Neurol201216373378doi: 10.1016/j.ejpn.2011.12.00522197452
    Back to article
  54. 54
    MohammadSSNosadiniMGrattan-SmithPDaleRCIntravenous immunoglobulin in acute Sydenham’s chorea: a systematic reviewJ Paediatr Child Health20155112351238doi: 10.1111/jpc.1291526633611
    Back to article
  55. 55
    SahinSCansuAA new alternative drug with fewer adverse effects in the treatment of Sydenham chorea: Levetiracetam Efficacy in a ChildClin Neuropharmacol201538144146doi: 10.1097/WNF.000000000000008426166232
    Back to article
  56. 56
    TeixeiraALJrMaiaDPCardosoFTreatment of acute Sydenham’s chorea with methyl-prednisolone pulse-therapyParkinsonism Relat Disord200511327330doi: 10.1016/j.parkreldis.2005.02.00715878690
    Back to article
  57. 57
    TeixeiraALJrMaiaDPCardosoFUFMG Sydenham’s chorea rating scale (USCRS): reliability and consistencyMov Disord200520585591doi: 10.1002/mds.2037715648075
    Back to article
  58. 58
    WHORheumatic fever and rheumatic heart disease: report of a WHO expert consultation. WHO Technical Report SeriesGenevaWHO2001923
    Back to article
  59. 59
    BerriosXQuesneyFMoralesABlazquezJBisnoALAre all recurrences of “pure” Sydenham chorea true recurrences of acute rheumatic fever?J Pediatr198510786772doi: 10.1016/S0022-3476(85)80177-33906071
    Back to article
  60. 60
    TerreriMTRojaSCLenCAFaustinoPCRobertoAMHilarioMOSydenham’s chorea—clinical and evolutive characteristicsSao Paulo Med J20021201619doi: 10.1590/S1516-3180200200010000511836548
    Back to article
  61. 61
    TeixeiraALCardosoFMaiaDPCunninghamMCSydenham's chorea may be a risk factor for drug induced parkinsonismJ Neurol Neurosurg Psychiatry20037413501351doi: 10.1136/jnnp.74.9.1350-a
    Back to article
  62. 62
    CardosoFSydenham’s choreaHandb Clin Neurol2011100221229doi: 10.1016/B978-0-444-52014-2.00014-821496581
    Back to article
  63. 63
    KaurNKumarPJamwalSDeshmukhRGauttamVTetrabenazine: spotlight on drug reviewAnn Neurosci201623176185doi: 10.1159/00044918427721587
    Back to article
  64. 64
    NausiedaPABieliauskasLABaconLDHagertyMKollerWCGlantzRNChronic dopaminergic sensitivity after Sydenham's choreaNeurology198333750754doi: 10.1212/WNL.33.6.7506188998
    Back to article
  65. 65
    GregorowskiCLochnerCMartinLet alNeuropsychological manifestations in children with Sydenham's chorea after adjunct intravenous immunoglobulin and standard treatmentMetab Brain Dis201631205212doi: 10.1007/s11011-015-9681-125987537
    Back to article
  66. 66
    EdgarTSOral pharmacotherapy of childhood movement disordersJ Child Neurol200318(Suppl. 1)S4049doi: 10.1177/0883073803018001S060113677570
    Back to article
  67. 67
    WalkerKGWilmshurstJMAn update on the treatment of Sydenham’s chorea: the evidence for established and evolving interventionsTher Adv Neurol Disord20103301309doi: 10.1177/175628561038206321179620
    Back to article
DOI: https://doi.org/10.5334/tohm.376 | Journal eISSN: 2160-8288
Journal RSS Feed
Language: English
Submitted on: Feb 20, 2017
Accepted on: May 9, 2017
Published on: Jun 1, 2017
Published by: Columbia University Libraries/Information Services
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Sydenham’s chorea,
rheumatic chorea,
treatment,
immunomodulatory,
valproic acid,
antipsychotic

© 2017 Shannon L. Dean, Harvey S. Singer, published by Columbia University Libraries/Information Services
This work is licensed under the Creative Commons License.

Previous articleVolume 7 (2017): Issue 0Next article